Daily functioning and symptom factors contributing to attitudes toward antipsychotic treatment and treatment adherence in outpatients with schizophrenia spectrum disorders

Show full item record



Permalink

http://hdl.handle.net/10138/324754

Citation

BMC Psychiatry. 2021 Jan 13;21(1):37

Title: Daily functioning and symptom factors contributing to attitudes toward antipsychotic treatment and treatment adherence in outpatients with schizophrenia spectrum disorders
Author: Leijala, J.; Kampman, O.; Suvisaari, J.; Eskelinen, S.
Publisher: BioMed Central
Date: 2021-01-13
URI: http://hdl.handle.net/10138/324754
Abstract: Abstract Background Poor adherence and negative attitudes to treatment are common clinical problems when treating psychotic disorders. This study investigated how schizophrenia core symptoms and daily functioning affect treatment adherence and attitudes toward antipsychotic medication and to compare patients using clozapine or other antipsychotics. Method A cross-sectional study with data from 275 patients diagnosed with schizophrenia spectrum disorder. Patients adherence, attitudes, insight and side-effects were evaluated using the Attitudes toward Neuroleptic Treatment scale. Overall symptomology was measured using the Brief Psychiatric Rating Scale (BPRS), the Health of the Nation Outcome Scale (HoNOS). The functioning was assessed using activities of daily living scale, instrumental activities of daily living scale and social functioning of daily living scale. Results Self-reported treatment adherence was high. Of the patients, 83% reported using at least 75% of the prescribed medication. Having more symptoms was related with more negative attitude towards treatment. There was a modest association with functioning and treatment adherence and attitude toward antipsychotic treatment. Attitudes affected on adherence in non-clozapine but not in clozapine groups. Conclusion Early detection of non-adherence is difficult. Systematic evaluation of attitudes toward the treatment could be one way to assess this problem, along with optimized medication, prompt evaluation of side effects and flexible use of psychosocial treatments.
Subject: Adherence
Compliance
Psychotic disorder
Attitudes toward neuroleptic treatment scale
Clozapine
Rights: The Author(s)


Files in this item

Total number of downloads: Loading...

Files Size Format View
12888_2021_Article_3037.pdf 548.9Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record